Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by McGuireWoods LLP ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7 8  
>>Next
 
Title
Country
Organisation
Author
Date
1
Healthcare & Life Sciences Private Equity Deal Tracker: Atreca Secures $56 Million In Funding
Atreca, based in Redwood City, California, is a privately held biotechnology company developing therapeutics drawn from human immune responses, including anti-cancer immune responses.
United States
19 Nov 2015
2
Healthcare & Life Sciences Private Equity Deal Tracker: AMO Pharma Secures $25 Million In Financing
AMO Pharma Limited has announced it has secured $25 million in private equity financing.
United States
13 Oct 2015
3
IGPA 2015 Focuses On Biosimilars, Quality, And Harmonization In Toronto-Part One Of Two
On September 16-18, 2015 the International Generic Pharmaceutical Alliance (IGPA) held its 18th Annual Meeting in Toronto, Canada.
United States
6 Oct 2015
4
Biosimilars Patent Litigation In The EU And US: A Comparative Strategic Overview
Biosimilars are highly similar versions of reference biological products, some with the potential to be deemed "interchangeable" by regulatory bodies, such as the US Food and Drug Administration (FDA).
United States
2 Oct 2015
5
IGPA 2015 Focuses On Biosimilars, Quality, And Harmonization In Toronto-Part Two Of Two
This is the second part of coverage of the 18th Annual International Generic Pharmaceutical Alliance (IGPA) Meeting held in Toronto, Canada on September 16-18, 2015.
Worldwide
1 Oct 2015
6
Healthcare & Life Sciences Private Equity Deal Tracker: Metacrine Secures $36 Million In Financing
Metacrine, based in San Diego, Calif., is a biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies.
United States
14 Aug 2015
7
Healthcare & Life Sciences Private Equity Deal Tracker: Oncobiologics Secures $31 Million In Financing
Oncobiologics, based in Cranbury, N.J., is a biopharmaceutical company focused on developing and commercializing monoclonal antibody biosimilar therapeutics.
United States
30 Jul 2015
8
Biomanufacturing Technology Summit 2015 In Maryland: Bioanalytics Guiding Quality, Where Increased Collaboration Could Lead To Faster And Greater Discoveries
The Summit concluded with a robust panel discussion from the day where there was considerable discussion about how long it takes for an analytic method to become a standard...
United States
5 Jul 2015
9
DIA 2015 Provides Panels On All Types Of FDA-Regulated Products With Many Opportunities For Insight And Interaction – Part Two Of Two
On the third day, the Center for Biologics Evaluation and Research (CBER) conducted its own Town Hall.
United States
25 Jun 2015
10
DIA 2015 Provides Panels On All Types Of FDA-Regulated Products With Many Opportunities For Insight And Interaction – Part One Of Two
On June 15-18, 2015 the Drug Information Association (DIA) held its 51st Annual Meeting in Washington, D.C.
United States
25 Jun 2015
11
Book 16 Meetings With Life Science Investors One Day At RESI
This one-day conference provides the highest ROI in the industry by bringing together innovative technology and active early stage investors looking to deploy capital.
United States
26 May 2015
12
Healthcare & Life Sciences Private Equity Deal Tracker: Rapid Micro Biosystems Secures $25 Million In Financing
Rapid Micro Biosystems has announced it has secured $25 million in series C funding.
United States
6 May 2015
13
Lux Capital Raises $350 Million Fund To Back Startup Healthcare And Technology Companies
Lux Capital has announced it has closed a new $350 million fund that will invest in early-stage science and technology ventures.
United States
15 Apr 2015
14
Healthcare & Life Sciences Private Equity Deal Tracker: OrthoSensor Secures $19 Million In Financing
OrthoSensor has announced it has raised $19 million in a private placement of series C preferred stock.
United States
1 Apr 2015
15
First U.S. Biosimilar Zarxio® (filigrastim-sndz) Approved: Issues Remain
Biologics are medicines that generally come from living organisms, which can include humans, animals and microorganisms such as yeast and bacteria.
United States
19 Mar 2015
16
Healthcare & Life Sciences Private Equity Deal Tracker: Vascular Dynamics Secures $17 Million in Financing
Vascular Dynamics has announced it has secured $16.85 million in series B financing.
United States
21 Jan 2015
17
Healthcare & Life Sciences Private Equity Deal Tracker: Assurex Health Secures $30 Million In Financing
Assurex Health has announced it has secured $30 million in equity financing.
United States
8 Jan 2015
18
Healthcare & Life Sciences Private Equity Deal Tracker: CardioDx Secures $35 Million In Financing
CardioDx has announced it has secured $35 million in total equity financing.
United States
2 Jan 2015
19
Healthcare & Life Sciences Private Equity Deal Tracker: Direct Flow Medical Secures $32 Million In Financing
Direct Flow Medical has announced it closed a new round of financing totaling $32 million.
United States
16 Dec 2014
20
Healthcare & Life Sciences Private Equity Deal Tracker: VytronUS Secures $31.6 Million In Financing
VytronUS has announced it has secured $31.6 million in an oversubscribed series B financing.
United States
5 Nov 2014
Links to Result pages
 
1 2 3 4 5 6 7 8  
>>Next